| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.01M | 15.01M | 25.39M | 21.88M | 18.36M | 11.77M |
| Gross Profit | 6.40M | 6.40M | 19.04M | 21.20M | 16.62M | 11.22M |
| EBITDA | 3.29M | 738.00K | 28.47M | 0.00 | -1.72M | 0.00 |
| Net Income | 2.00M | 2.00M | 11.61M | 19.59M | 20.39M | 13.95M |
Balance Sheet | ||||||
| Total Assets | 268.60M | 268.60M | 238.31M | 221.52M | 183.73M | 105.91M |
| Cash, Cash Equivalents and Short-Term Investments | 19.77M | 19.77M | 36.26M | 41.73M | 26.54M | 15.96M |
| Total Debt | 88.33M | 88.33M | 70.88M | 55.07M | 48.85M | 18.13M |
| Total Liabilities | 91.05M | 91.05M | 73.03M | 57.26M | 50.79M | 20.13M |
| Stockholders Equity | 177.55M | 177.55M | 165.28M | 164.26M | 132.94M | 85.79M |
Cash Flow | ||||||
| Free Cash Flow | 10.28M | 21.52M | 16.92M | 10.72M | 71.92M | 9.40M |
| Operating Cash Flow | 17.16M | 21.52M | 16.92M | 10.72M | 9.34M | 7.53M |
| Investing Cash Flow | -22.87M | -22.87M | -26.38M | -25.17M | -61.83M | -8.42M |
| Financing Cash Flow | 22.69M | 18.33M | -2.75M | 17.71M | 56.49M | -1.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £188.80M | 12.76 | 13.07% | 8.15% | 1.29% | 11.17% | |
72 Outperform | £110.38M | 14.09 | 30.60% | 8.61% | -11.43% | -17.65% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £117.30M | 35.26 | 1.79% | 3.29% | -9.37% | ― | |
64 Neutral | £145.16M | 11.74 | 9.72% | 21.31% | -15.65% | -12.27% | |
63 Neutral | £135.59M | 28.16 | 1.17% | 9.74% | 2.13% | -61.22% | |
62 Neutral | £196.69M | 10.38 | 16.48% | 17.93% | -16.53% | -44.15% |
Duke Capital Limited has made a £3 million follow-on investment in its existing partner Tristone Healthcare, a specialist provider of residential, nursing and domiciliary care for high-acuity adults with complex needs and for children and young people requiring care, support and specialist education. The new funding will increase Duke’s equity stake in Tristone from 28.4% to a 51% majority holding and provide additional credit financing, taking total credit support to £24.3 million on unchanged terms with a 13.5% yield. The capital injection is designed to give Tristone sufficient liquidity to meet deferred consideration obligations from prior bolt-on acquisitions and to support continued expansion, following a period in which management has increased residential capacity from 200 to more than 250 places and delivered record monthly revenues, thereby deepening Duke’s exposure to a growing healthcare platform while reinforcing income visibility for its own shareholders.
The most recent analyst rating on (GB:DUKE) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited announced an interim dividend of 0.70 pence per share for the third quarter of the financial year, continuing its commitment to providing returns to shareholders. With payment set for January 2026, this demonstrates Duke’s focus on maintaining strong shareholder engagement and financial performance, reinforcing its position as a reliable capital partner for SMEs in its markets.
The most recent analyst rating on (GB:DUKE) stock is a Hold with a £30.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited reported its interim financial results for the six months ending September 30, 2025, showcasing resilience and a platform for growth despite challenging market conditions. The company achieved a recurring cash revenue of £13.2 million, a 3% increase from the previous year, and maintained a free cash flow of £5.9 million. Duke Capital’s disciplined investment strategy led to over £15 million in deployments to existing capital partners, supporting strategic acquisitions and organic expansion. The company anticipates a 5% increase in recurring cash revenue in Q3 FY26 and has made significant investments, including acquiring Galway Bay FM. Despite market headwinds, Duke Capital remains focused on delivering long-term shareholder value through disciplined capital allocation and a robust balance sheet.
The most recent analyst rating on (GB:DUKE) stock is a Hold with a £28.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.
Duke Capital Limited has announced a follow-on investment of £3.7 million into Step Investments Limited, enabling Step’s subsidiary, Bay Broadcasting Limited, to acquire Galway Bay FM, a leading radio station in Galway, Ireland. This acquisition expands Bay’s portfolio to four prominent Irish radio stations and positions it as the second largest commercial radio group in Ireland. The financing increases Duke’s total credit financing in Step to £15.2 million, reflecting Duke’s ongoing support and strategic partnership with Step to enhance its media asset portfolio across the UK and Ireland.
The most recent analyst rating on (GB:DUKE) stock is a Hold with a £28.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.